Lemaitre Vascular Inc. (LMAT)
LeMaitre Vascular: The Compounder Keeps Compounding
LeMaitre Vascular delivered strong Q4 and FY 2025 results, with 16% YoY sales growth and broad-based margin expansion. Artegraft's international rollout exceeded expectations, with 2025 sales doubling guidance and a projected $10M in 2026. This could drive earnings growth for years to come. LMAT maintains a robust $190M net cash position and recently increased its dividend by 25%. The board has also authorized a $100M share repurchase program.
LeMaitre Vascular, Inc. (LMAT) Q4 2025 Earnings Call Transcript
LeMaitre Vascular, Inc. (LMAT) Q4 2025 Earnings Call Transcript
3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT)
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
LeMaitre Vascular (LMAT) Q3 Earnings Surpass Estimates
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.49 per share a year ago.
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
LeMaitre Vascular, Inc. (LMAT) Q2 2025 Earnings Call Transcript
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants David B. Roberts - President & Director Dorian LeBlanc - Chief Financial Officer George W.
LeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.52 per share a year ago.
LeMaitre Vascular, Inc. (LMAT) Q1 2025 Earnings Call Transcript
LeMaitre Vascular, Inc. (LMAT) Q1 2025 Earnings Call Transcript
LeMaitre Vascular (LMAT) Lags Q1 Earnings Estimates
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.48 per share, missing the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.44 per share a year ago.
LeMaitre (LMAT) Soars 7.7%: Is Further Upside Left in the Stock?
LeMaitre (LMAT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
3 Reasons Growth Investors Will Love LeMaitre (LMAT)
LeMaitre (LMAT) could produce exceptional returns because of its solid growth attributes.
Best Momentum Stocks to Buy for March 4th
OPCH and LMAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 4, 2025.
